Suppr超能文献

部分心脏移植 - 如何改变系统。

Partial Heart Transplantation - How to Change the System.

机构信息

Congenital Heart Surgery Research and Training Laboratory, Duke University, Durham, North Carolina.; Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.

Medical University of South Carolina, Charleston, South Carolina.; Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.

出版信息

Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2024;27:100-105. doi: 10.1053/j.pcsu.2024.01.002. Epub 2024 Jan 23.

Abstract

Partial heart transplantation is the first clinically successful approach to deliver growing heart valve implants. To date, 13 clinical partial heart transplants have been performed. However, turning partial heart transplantation into a routine procedure that is available to all children who would benefit from growing heart valve implants poses formidable logistical challenges. Firstly, a supply for partial heart transplant donor grafts needs to be developed. This challenge is complicated by the scarcity of donor organs. Importantly, the donor pools for orthotopic heart transplants, partial heart transplants and cadaver homografts overlap. Secondly, partial heart transplants need to be allocated. Factors relevant for equitable allocation include the indication, anatomical fit, recipient clinical status and time on the wait list. Finally, partial heart transplantation will require regulation and oversight, which only recently has been undertaken by the Food and Drug Administration, which regulates human cellular and tissue-based products. Overcoming these challenges will require a change in the system. Once this is achieved, partial heart transplantation could open new horizons for children who require growing tissue implants.

摘要

部分心脏移植是临床成功实现生长型心脏瓣膜植入物的第一种方法。迄今为止,已经进行了 13 例临床部分心脏移植。然而,要将部分心脏移植转化为一种常规程序,为所有受益于生长型心脏瓣膜植入物的儿童提供这种治疗,这就带来了严峻的后勤挑战。首先,需要开发部分心脏移植供体移植物的供应。由于供体器官稀缺,这一挑战变得更加复杂。重要的是,用于原位心脏移植、部分心脏移植和同种异体尸体移植物的供体池是重叠的。其次,需要分配部分心脏移植。公平分配的相关因素包括适应证、解剖学适配、受者临床状况和等待名单上的时间。最后,部分心脏移植需要监管,这一点最近才由美国食品和药物管理局(FDA)负责,FDA 负责监管人体细胞和组织产品。克服这些挑战需要对系统进行变革。一旦实现这一目标,部分心脏移植可能为需要生长组织植入物的儿童开辟新的前景。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验